Archived Insight | May 5, 2020

Key Workforce Strategies for Coping with the COVID-19 Crisis

In addition to the public health challenges it poses, the coronavirus has forced institutions of higher learning to manage their workforces with an unprecedented amount of efficiency and innovation.

The session will present several strategies for addressing workforce challenges associated with the financial impacts of the COVID-19 crisis. The strategies will cover a path for developing and analyzing various operational scenarios and their impact on the workforce. We’ll review effective strategies for:

• Deploying restructuring
• Reducing the workforce
• Leading cost reduction
• Revenue generation

higher education covid workforce webinar

Download the slides from this webinar

Don't have time to watch a video right now? No worries. You can download the slides from this webinar here.

Download Here

Still have questions about workforce strategies?

We're happy to discuss how we can help you guide your workforce to success. Get in touch with one of our professionals and let's start a conversation.

Learn more from Segal

Asian Female Pharmacist Uses Computer To Check Inventory For A Drug

Designing and Negotiating Affordable Pharmacy Benefits

Learn how health plan sponsors can improve pharmacy benefit value through PBM contracting, formulary management and clinical oversight.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical, Healthcare Cost Management

Read Full Insight

Focused Business Woman Working On Laptop Computer Reading

Many Retirement Plans Must Be Amended by December 31, 2026

Learn which retirement plans must be amended by December 31, 2026 and how SECURE Act discretionary and required amendments differ.

Retirement, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate

Read Full Insight

Man Self Injecting GLP 1 Weight Loss Medication Pen At Home

GLP-1s Have Disrupted the Market for Other Diabetes Drugs

Segal’s SHAPE data shows how rising GLP-1 use coincided with declines in insulin, Metformin and DPP-4 inhibitor use.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Corporate, Pharmaceutical

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.